MUSTANG BIO, INC. Quarterly Nonoperating Income (Expense) in USD from Q2 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Mustang Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2015 to Q3 2024.
  • Mustang Bio, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $47K, a 81.1% decline year-over-year.
  • Mustang Bio, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $553K.
  • Mustang Bio, Inc. annual Nonoperating Income (Expense) for 2023 was -$2.34M, a 71.4% decline from 2022.
  • Mustang Bio, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.37M, a 487% decline from 2021.
  • Mustang Bio, Inc. annual Nonoperating Income (Expense) for 2021 was $353K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $553K $47K -$202K -81.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $755K $341K +$2.69M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$1.93M $40K +$412K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$2.34M $125K +$327K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 -$2.67M $249K +$398K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$3.07M -$2.34M -$1.49M -173% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$1.58M -$372K -$215K -137% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$1.37M -$202K -$272K -389% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$1.09M -$149K -$221K -307% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$873K -$858K -$939K -1159% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $66K -$157K -$287K -221% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $353K $70K -$60K -46.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $413K $72K +$2.6M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$2.18M $81K +$558K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$2.74M $130K +$467K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$3.21M $130K +$416K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$3.63M -$2.53M -$2.35M -1368% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$1.27M -$477K -$290K -155% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$982K -$337K -$478K -339% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$504K -$286K -$416K -320% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 -$88K -$172K -$310K -225% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $222K -$187K -$334K -227% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $556K $141K -$5K -3.43% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $561K $130K +$1K +0.78% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $560K $138K -$6K -4.17% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 $566K $147K +$11K +8.09% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 $555K $146K +$58K +65.9% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 $497K $129K +$1.05M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$549K $144K +$344K Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$893K $136K +$229K Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$1.12M $88K +$169K Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$1.29M -$917K -$849K -1249% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 -$442K -$200K -$142K -245% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-29
Q2 2016 -$300K -$93K -$51K -121% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-29
Q1 2016 -$249K -$81K Jan 1, 2016 Mar 31, 2016 10-K 2018-03-29
Q4 2015 -$68K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$58K Jul 1, 2015 Sep 30, 2015 10-K 2017-03-31
Q2 2015 -$42K Apr 1, 2015 Jun 30, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.